DS
IMNM icon

DRW Securities’s Immunome IMNM Stock Holding History

DRW Securities’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
+17,686
New +$378K 0.01% 505
2025
Q4 		– Sell
-24,355
Closed -$250K – 1441
2025
Q3 		$250K Sell
24,355
-3,744
-13% -$37.2K ﹤0.01% 948
2025
Q2 		$261K Buy
+28,099
New +$230K 0.01% 800

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

DRW Securities's IMNM Position: Q2 2026 in Review

DRW Securities opened a new position in Immunome (IMNM) in Q2 2026: 17,686 shares worth $375K. The stake represents 0.01% of the portfolio and ranks #505 among its holdings. This is a return to the name: DRW Securities previously reported a position in IMNM as recently as Q3 2025.

DRW Securities first reported a position in IMNM in Q2 2025 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • DRW Securities held 17,686 shares of Immunome worth $375K as of Q2 2026.
  • Immunome was a new DRW Securities position in Q2 2026.
  • Immunome made up 0.01% of DRW Securities's portfolio in Q2 2026, its #505 holding.
  • DRW Securities first reported a position in Immunome in Q2 2025 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.